about
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas.Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulationGain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expressionProtumorigenic effects of mir-145 loss in malignant pleural mesothelioma.Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors.Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective study.The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex.MiRNA-513a-5p Inhibits Progesterone Receptor Expression and Constitutes a Risk Factor For Breast Cancer: The ORDET Prospective Study.Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.microRNAs in Cancer Chemoprevention: Method to Isolate Them from Fresh Tissues.Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma.MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.MicroRNA expression profiling of thymic epithelial tumors.Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumors
P50
Q31814759-85C6F73E-2C88-487D-B0AE-B14D43B9D72BQ33655180-7775036E-76E1-4BE8-9E3A-B356146C143AQ35742357-6DBB2DB7-0AC9-43B3-A3BB-8A10D8DB7649Q36394044-66AE19A0-E7E8-49F9-9C58-37350DDCB814Q36843755-5CEFF207-EC7C-47DA-9F4C-4E006B3EFAEAQ37344081-BDC05C27-23DC-42CD-8769-611384C8748FQ42511555-5CC0E688-FAE7-45B9-90A7-21F7B5B03FC3Q44631412-7123A399-B28C-4FBB-9D5C-C0DDF5C6E838Q47097104-874CE1BB-9079-49D3-950F-4B13034AF3E8Q47617574-00C1F0FA-4A4F-4725-A006-9FFBD3ACA105Q48088749-40C7E146-E6DA-4E1D-A5D0-6257E72F1EBEQ50547527-D086033F-25EE-4309-843A-1728D8F759E4Q51416797-85479A5B-0D3F-4EFB-BDFB-248DC3338E3EQ53226065-76742D5C-D8A9-4D79-BF30-B7F659C03F80Q53236925-6B8E9CE7-06C7-4751-A0B8-1337F951EF27Q83470648-0D7F2385-A410-4D96-A1DC-013704A2F496
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
F Ganci
@ast
F Ganci
@en
F Ganci
@es
F Ganci
@nl
type
label
F Ganci
@ast
F Ganci
@en
F Ganci
@es
F Ganci
@nl
altLabel
Federica Ganci
@en
prefLabel
F Ganci
@ast
F Ganci
@en
F Ganci
@es
F Ganci
@nl
P1053
K-9857-2016
P106
P1153
42061197600
P21
P31
P496
0000-0002-8010-2183